| PERIOD ENDING | 31-Jan-09 | 26-Jan-08 | 27-Jan-07 | | Total Revenue | 18,999,505 | 18,647,126 | 17,404,637 | | Cost of Revenue | 14,394,756 | 14,082,448 | 13,213,703 | | | Gross Profit | 4,604,749 | 4,564,678 | 4,190,934 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 3,170,018 | 3,126,565 | 2,928,520 | | Non Recurring | (30,500) |
-
|
-
| | Others |
-
| 197,022 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,465,231 | 1,241,091 | 1,262,414 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1,598 |
-
| | Earnings Before Interest And Taxes | 1,465,231 | 1,242,689 | 1,262,414 | | Interest Expense | 14,291 |
-
| 15,566 | | Income Before Tax | 1,450,940 | 1,242,689 | 1,246,848 | | Income Tax Expense | 536,054 | 470,939 | 470,092 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 914,886 | 771,750 | 776,756 | | | Non-recurring Events | | Discontinued Operations | (34,269) |
-
| (38,717) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 880,617 | 771,750 | 738,039 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $880,617 | $771,750 | $738,039 |
|
1.48% Nasdaq 
Income Statement
